Welcome to My Yahoo

Get your headlines, email, quotes and more — all in one place.

Existing user?

Ashburn, Virginia (Current location)

43°
Partly Cloudy
Today
57°40°
Sun
58°33°
Mon
63°46°
Tue
45°35°
Wed
47°30°
See More »

Scoreboard

More scores »

Horoscope

Sagittarius(change)
November 28 - It's the little things that make life special, so pay close attention while you wash dishes or proofread that report. You can find grace almost anywhere on a day like today, and it's worth the search.

BuzzFeed - Entertainment

Today

More on Yahoo.com »

News For You

  • Thomson Reuters StreetEvents

    Edited Transcript of BMKB.L earnings conference call or presentation 27-Nov-20 8:30am GMT

    Full Year 2020 Benchmark Holdings PLC Earnings Call

    Thomson Reuters StreetEvents

    Edited Transcript of BMKB.L earnings conference call or presentation 27-Nov-20 8:30am GMT

    Full Year 2020 Benchmark Holdings PLC Earnings Call

  • FX Empire

    Ethereum, Litecoin, and Ripple’s XRP – Daily Tech Analysis – November 28th, 2020

    It’s a bearish start to the day for the majors. Failure to move back through early highs would bring support levels into play.

    FX Empire

    Ethereum, Litecoin, and Ripple’s XRP – Daily Tech Analysis – November 28th, 2020

    It’s a bearish start to the day for the majors. Failure to move back through early highs would bring support levels into play.

  • InStyle

    The Best (Non-Material) Gifts to Give Yourself This Holiday Season

    Mental health pros share the most meaningful "gifts" to set yourself up for personal growth in the year ahead.

    InStyle

    The Best (Non-Material) Gifts to Give Yourself This Holiday Season

    Mental health pros share the most meaningful "gifts" to set yourself up for personal growth in the year ahead.

  • Reuters Videos

    Questions over AstraZeneca's COVID-19 vaccine data

    AstraZeneca is working with regulators to investigate a lower dosage of its experimental COVID-19 vaccine that performed better than a full dosage. That’s according to a spokesman for the company, who made the statement after its CEO was quoted as saying an additional global trial was likely - instead of adding the trial to an ongoing U.S. process. Asked about a Bloomberg report which quoted CEO Pascal Soriot, an AstraZeneca spokesman said : "As we communicated earlier this week, there is strong merit in continuing to further investigate the half-dose/full dose regimen." News of a likely additional trial comes as AstraZeneca faces questions about its success rate that some experts say could harm its chances of getting speedy U.S. and EU approval. Several scientists have cast doubts on results released Monday showing the experimental vaccine was 90% effective in a sub-group of trial participants who, by error initially, received a half dose followed by a full dose. AstraZeneca told Reuters earlier on Thursday that administering of the half dose had been reviewed and approved by independent monitors and the UK regulator. Clearance from the U.S. Food and Drug Administration may take longer though because the agency is unlikely to approve the vaccine based on studies carried out elsewhere, according to Soriot, especially given the questions over the results.

    Reuters Videos

    Questions over AstraZeneca's COVID-19 vaccine data

    AstraZeneca is working with regulators to investigate a lower dosage of its experimental COVID-19 vaccine that performed better than a full dosage. That’s according to a spokesman for the company, who made the statement after its CEO was quoted as saying an additional global trial was likely - instead of adding the trial to an ongoing U.S. process. Asked about a Bloomberg report which quoted CEO Pascal Soriot, an AstraZeneca spokesman said : "As we communicated earlier this week, there is strong merit in continuing to further investigate the half-dose/full dose regimen." News of a likely additional trial comes as AstraZeneca faces questions about its success rate that some experts say could harm its chances of getting speedy U.S. and EU approval. Several scientists have cast doubts on results released Monday showing the experimental vaccine was 90% effective in a sub-group of trial participants who, by error initially, received a half dose followed by a full dose. AstraZeneca told Reuters earlier on Thursday that administering of the half dose had been reviewed and approved by independent monitors and the UK regulator. Clearance from the U.S. Food and Drug Administration may take longer though because the agency is unlikely to approve the vaccine based on studies carried out elsewhere, according to Soriot, especially given the questions over the results.

  • FX Empire

    USD/CAD Daily Forecast – Test Of Support At 1.2985

    USD/CAD managed to get below the support at 1.3000 and is testing the next support level at 1.2985.

    FX Empire

    USD/CAD Daily Forecast – Test Of Support At 1.2985

    USD/CAD managed to get below the support at 1.3000 and is testing the next support level at 1.2985.

  • Reuters

    EMERGING MARKETS-Latam FX dips; Brazil's real gains on improving prospects

    * U.S. holiday gives few trading cues to stocks * Real stabilizing, Brazil central bank head says * Petrobras shares down after firm cuts spending plan By Ambar Warrick Nov 26 (Reuters) - Brazil's real ticked higher on Thursday after encouraging comments from the central bank president, while most other Latin American units edged lower as optimism over a coronavirus vaccine waned. The real added 0.3% after central bank president Roberto Campos Neto said the currency looked to have stopped weakening and was now stabilizing, indicating that upward pressure on inflation this year will ease. The country reported its smallest monthly primary deficit since the advent of the pandemic, indicating a recovery in Latin America's largest economy was underway.

    Reuters

    EMERGING MARKETS-Latam FX dips; Brazil's real gains on improving prospects

    * U.S. holiday gives few trading cues to stocks * Real stabilizing, Brazil central bank head says * Petrobras shares down after firm cuts spending plan By Ambar Warrick Nov 26 (Reuters) - Brazil's real ticked higher on Thursday after encouraging comments from the central bank president, while most other Latin American units edged lower as optimism over a coronavirus vaccine waned. The real added 0.3% after central bank president Roberto Campos Neto said the currency looked to have stopped weakening and was now stabilizing, indicating that upward pressure on inflation this year will ease. The country reported its smallest monthly primary deficit since the advent of the pandemic, indicating a recovery in Latin America's largest economy was underway.

  • People

    Kate Middleton's Survey Unveils 'Serious Milestone' In Her Long-Running Work for Young Families

    The Duchess of Cambridge is unveiling the results of her under-fives project: 'Homelessness, addiction, poor mental health are often grounded in a difficult childhood'

    People

    Kate Middleton's Survey Unveils 'Serious Milestone' In Her Long-Running Work for Young Families

    The Duchess of Cambridge is unveiling the results of her under-fives project: 'Homelessness, addiction, poor mental health are often grounded in a difficult childhood'

See All Stories »

My Mail

  • Check multiple mail
  • accounts from one place

My Portfolio

Last updated at 3:28 AM EST
Oops, something went wrong and we could not fetch your portfolio information. Please try again.
Markets
SymbolPriceChange% Chg
^GSPC3,638.358.700.24%
^DJI29,910.3737.900.13%
^IXIC12,205.85111.440.92%
^RUT1,855.2710.250.56%
CL=F45.53-0.18-0.39%
GC=F1,781.90-23.60-1.31%
SI=F22.64-0.81-3.44%
EURUSD=X1.200.010.48%
^TNX0.84-0.04-4.10%
GBPUSD=X1.33-0.00-0.32%
JPY=X104.05-0.20-0.19%
BTC-USD16,980.55-204.80-1.19%
^CMC200333.27-4.23-1.25%
^FTSE6,367.584.650.07%
^N22526,644.71107.400.40%

TechCrunch

NYT Health